Exoribonuclease 1 (ERI1) (C-Term) Peptid
Kurzübersicht für Exoribonuclease 1 (ERI1) (C-Term) Peptid (ABIN8100069)
Target
Quelle
Applikation
-
-
Protein Region
- C-Term
-
Verwendungszweck
- THEX1 Peptide - C-terminal region
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-THEX1 antibody ( ARP41158_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- ERI1 (Exoribonuclease 1 (ERI1))
-
Hintergrund
-
Background Information: THEX1 contains 1 SAP domain and 1 exonuclease domain. It is an RNA exonuclease that binds to the 3' end of histone mRNAs and probably degrades them, suggesting that it plays an essential role in histone mRNA decay after replication. It is also able to degrade the 3' overhangs of short interfering RNAs (siRNAs) in vitro, suggesting a possible role as regulator of RNA interference (RNAi).
Alternative Symbols: HEXO, THEX1, 3'HEXO
-
Molekulargewicht
- 38kDa
-
Gen-ID
- 90459
-
NCBI Accession
- NP_699163
-
UniProt
- Q8IV48
Target
-